TIPE2 and ovarian serous cystadenocarcinoma: The expression data in the GTEx database indicated that TNFAIP8L2 was highly expressed in most tumors, particularly in glioblastoma multiforme (GBM), kidney chromophobe (KICH), acute myeloid leukemia (AML), brain lower grade glioma (LGG), ovarian serous cystadenocarcinoma (OV), stomach adenocarcinoma (STAD) and testicular germ cell tumors (TGCT).